GALEGENIMAB

UNII:	UTI65JH23L
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	GALEGENIMAB
GSRS Full Record:	UTI65JH23L i

2403683-24-7
FHTR-2163
FHTR2163
GALEGENIMAB [USAN]
Galegenimab [WHO-DD]
Immunoglobulin IgG1 Fab fragment, anti-(human serine proteinase HtrA1) (human-Mus musculus monoclonal FHTR2163 γ1-chain), disulfide with human-Mus musculus monoclonal FHTR2163 κ-chain
RG-6147
RG6147
RO-7171009
RO7171009
galegenimab [INN]
immunoglobulin Fab G1-kappa, anti-[Homo sapiens HTRA1 (HtrA serine peptidase 1, protease serine 11 (IGF binding), PRSS11, IGFBP5-protease, ARMD7)], humanized monoclonal antibody; VH-(CH1-hinge) gamma1 heavy chain humanized (1-223) [VH (Homo sapiens IGHV1-46*01 (77.6%) -(IGHD) - IGHJ4*01 (92.9%), CDR-IMGT [8.8.12] (26-33.51-58.97-108)) (1-119) -CH1- hinge (Homo sapiens IGHG1*01 (100%), G1m17 (CH1 K120 (216) (120-217), hinge 1-7 (218-223)) (120-223)], (222-213')-disulfide with kappa light chain humanized (1'-213') [V-KAPPA (Homo sapiens IGKV1-39*01 (84.2%) - IGKJ1*01 (100%), CDR-IMGT [5.3.9] (27-31.49-51.88-96)) (1'-106') -Homo sapiens IGKC*01 (100%), Km3 A45.1 (152), V101 (190) (107'-213')], produced in the bacteria Escherichia coli (E. coli), non-glycosylated

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

GALEGENIMAB

Synonyms and Mappings

Resources